• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核激素受体共抑制因子RIP13/N-CoR中的两个受体相互作用结构域。

Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.

作者信息

Seol W, Mahon M J, Lee Y K, Moore D D

机构信息

Department of Molecular Biology, Massachusetts General Hospital, Boston 02114, USA.

出版信息

Mol Endocrinol. 1996 Dec;10(12):1646-55. doi: 10.1210/mend.10.12.8961273.

DOI:10.1210/mend.10.12.8961273
PMID:8961273
Abstract

The thyroid hormone receptor (TR) and the retinoic acid receptor (RAR) act as transcriptional repressors when they are not occupied by their cognate ligands. This repressor function is mediated by proteins called corepressors. One of the nuclear hormone receptor corepressors, N-CoR, was originally isolated as a retinoid X receptor-interacting protein called RIP13. We have isolated a new potential variant of RIP13/N-CoR that is missing previously described transcriptional repressor domains but is similar in structure to the related corepressor termed SMRT or TRAC-2. Detailed analysis of the interaction with TR and RAR demonstrates that RIP13/N-CoR contains a new receptor interaction domain, termed ID-II, in addition to the previously described domain, referred to here as ID-I. Both ID-I and ID-II are capable of interacting independently with either TR or RAR, as assessed by the yeast two-hybrid system, by a mammalian two-hybrid system, or by direct in vitro binding. Results with all three approaches confirm that RIP13/N-CoR also interacts with retinoid X receptor, but this interaction is weaker than that with TR or RAR. Together, these results demonstrate that RIP13/N-CoR can interact with several different nuclear hormone receptors via two separate receptor interaction domains. Differences between the interactions observed in the different systems suggest that corepressor function may be modified by additional factors present in various cell types.

摘要

甲状腺激素受体(TR)和视黄酸受体(RAR)在未被其同源配体占据时作为转录抑制因子发挥作用。这种抑制功能由一类称为共抑制因子的蛋白质介导。核激素受体共抑制因子之一,N-CoR,最初是作为一种与视黄酸X受体相互作用的蛋白质RIP13被分离出来的。我们分离出了一种新的RIP13/N-CoR潜在变体,它缺失了先前描述的转录抑制结构域,但在结构上与相关的共抑制因子SMRT或TRAC-2相似。对其与TR和RAR相互作用的详细分析表明,RIP13/N-CoR除了先前描述的结构域(这里称为ID-I)外,还包含一个新的受体相互作用结构域,称为ID-II。通过酵母双杂交系统、哺乳动物双杂交系统或直接体外结合评估发现,ID-I和ID-II都能够独立地与TR或RAR相互作用。这三种方法的结果均证实RIP13/N-CoR也与视黄酸X受体相互作用,但这种相互作用比与TR或RAR的相互作用弱。总之,这些结果表明RIP13/N-CoR可以通过两个独立的受体相互作用结构域与几种不同的核激素受体相互作用。在不同系统中观察到的相互作用之间的差异表明,共抑制因子的功能可能会被各种细胞类型中存在的其他因素所改变。

相似文献

1
Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.核激素受体共抑制因子RIP13/N-CoR中的两个受体相互作用结构域。
Mol Endocrinol. 1996 Dec;10(12):1646-55. doi: 10.1210/mend.10.12.8961273.
2
The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.核激素受体与共抑制因子之间相互作用的特异性是由相互作用结构域内不同的氨基酸序列介导的。
Mol Endocrinol. 2001 Jul;15(7):1049-61. doi: 10.1210/mend.15.7.0669.
3
Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors.共抑制因子N-CoR/RIP13中的两个受体相互作用结构域是与Rev-erbAα和RVR高效相互作用所必需的:物理结合依赖于孤儿受体的E区域。
Nucleic Acids Res. 1996 Nov 15;24(22):4379-86. doi: 10.1093/nar/24.22.4379.
4
Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.RVR和Rev-erbAα中一个新型共抑制因子相互作用区域的鉴定与表征
Mol Endocrinol. 1998 Feb;12(2):248-62. doi: 10.1210/mend.12.2.0061.
5
Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.共抑制因子SMRT的受体相互作用及转录抑制作用的表征
Mol Endocrinol. 1997 Dec;11(13):2025-37. doi: 10.1210/mend.11.13.0028.
6
The nuclear corepressors recognize distinct nuclear receptor complexes.核共抑制因子识别不同的核受体复合物。
Mol Endocrinol. 2000 Jun;14(6):900-14. doi: 10.1210/mend.14.6.0474.
7
The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.维生素D受体与核受体共抑制因子和共激活因子的相互作用。
Biochem Biophys Res Commun. 1998 Dec 18;253(2):358-63. doi: 10.1006/bbrc.1998.9799.
8
Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).鸡卵清蛋白上游启动子转录因子I(COUP-TFI)介导的基因沉默是由转录共抑制因子、核受体共抑制因子(N-CoR)以及维甲酸受体和甲状腺激素受体沉默介质(SMRT)介导的。
Mol Endocrinol. 1997 Jun;11(6):714-24. doi: 10.1210/mend.11.6.0002.
9
Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.核受体共抑制因子与甲状腺激素受体相互作用的测定
Mol Endocrinol. 2003 Feb;17(2):273-86. doi: 10.1210/me.2002-0310.
10
The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.BCL-6 POZ结构域和其他POZ结构域与共抑制因子N-CoR和SMRT相互作用。
Oncogene. 1998 Nov 12;17(19):2473-84. doi: 10.1038/sj.onc.1202197.

引用本文的文献

1
Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.特异性剔除 NCoR 核心抑制因子 δ 剪接变异体揭示了可变剪接作为肝脏代谢关键调控因子的作用。
PLoS One. 2020 Oct 26;15(10):e0241238. doi: 10.1371/journal.pone.0241238. eCollection 2020.
2
Multiple mechanisms regulate H3 acetylation of enhancers in response to thyroid hormone.多种机制调节增强子的 H3 乙酰化以响应甲状腺激素。
PLoS Genet. 2020 May 26;16(5):e1008770. doi: 10.1371/journal.pgen.1008770. eCollection 2020 May.
3
Allosteric pathways in nuclear receptors - Potential targets for drug design.
核受体中的变构途径——药物设计的潜在靶点。
Pharmacol Ther. 2018 Mar;183:152-159. doi: 10.1016/j.pharmthera.2017.10.014. Epub 2017 Oct 31.
4
Corepressor diversification by alternative mRNA splicing is species specific.通过可变mRNA剪接实现的共抑制因子多样化具有物种特异性。
BMC Evol Biol. 2016 Oct 19;16(1):221. doi: 10.1186/s12862-016-0781-2.
5
Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.核受体共抑制因子 1(NCoR1)和沉默调节蛋白(SMRT)在稳态中的新兴作用。
Genes Dev. 2013 Apr 15;27(8):819-35. doi: 10.1101/gad.214023.113.
6
Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ-inducible protein 10 in a casein kinase 2-dependent manner.核激素受体共抑制因子通过依赖于酪蛋白激酶 2 的方式转录抑制干扰素-γ诱导蛋白 10 促进食管癌细胞侵袭。
Mol Biol Cell. 2012 Aug;23(15):2943-54. doi: 10.1091/mbc.E11-11-0947. Epub 2012 Jun 6.
7
SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.SMRTε 是一种核心抑制因子变体,与包括视黄酸受体 α 和 β 在内的有限数量的核受体相互作用。
Mol Cell Endocrinol. 2012 Apr 4;351(2):306-16. doi: 10.1016/j.mce.2012.01.006. Epub 2012 Jan 12.
8
Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.核心抑制物的可变剪接产生了在脂肪细胞分化中发挥相反作用的变异体。
J Biol Chem. 2011 Dec 30;286(52):44988-99. doi: 10.1074/jbc.M111.291625. Epub 2011 Nov 7.
9
Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation.丝氨酸/苏氨酸激酶(MAPK)磷酸化调控 SMRT 核心抑制因子二聚体形成和组成。
Mol Cell Endocrinol. 2011 Jan 30;332(1-2):180-8. doi: 10.1016/j.mce.2010.10.010. Epub 2010 Oct 19.
10
A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.一种独特的二级结构开关控制维甲酸受体对组成型基因的抑制作用。
Nat Struct Mol Biol. 2010 Jul;17(7):801-7. doi: 10.1038/nsmb.1855. Epub 2010 Jun 13.